Detailseite
Projekt Druckansicht

Ausnutzung mitochondrialer Anfälligkeit von Neuronen von Patienten mit Chorea Huntington zur Entdeckung neuer Behandlungsmöglichkeiten auf molekularer Ebene

Fachliche Zuordnung Molekulare und zelluläre Neurologie und Neuropathologie
Förderung Förderung von 2020 bis 2024
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 423776278
 
Erstellungsjahr 2024

Zusammenfassung der Projektergebnisse

In our project, we have demonstrated that the technology of iPSC reprogramming can be used to investigate the impact of HD on neurodevelopment. We have identified a novel target of intervention CHCHD2, which impacts neurodevelopment through a mitochondrial-related mechanism. Hence, mitochondrial dysfunction could represent a key mechanistic aspect in the early establishment of HD pathogenesis. We believe that our findings are important not only for the scientific community in the field of stem cells, HD, and mitochondria, but may also be worth sharing with the patient community and the general public. HD is a rare incurable disease and therefore it is important to increase awareness in the public. Affected patients and related families may be interested to hear about our scientific advances that have the potential to help establish new potential treatment options to some of the affected individuals.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung